NO20002721L - Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav - Google Patents

Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav

Info

Publication number
NO20002721L
NO20002721L NO20002721A NO20002721A NO20002721L NO 20002721 L NO20002721 L NO 20002721L NO 20002721 A NO20002721 A NO 20002721A NO 20002721 A NO20002721 A NO 20002721A NO 20002721 L NO20002721 L NO 20002721L
Authority
NO
Norway
Prior art keywords
preparation
methods
pharmaceutical preparations
heterocyclic compounds
gastric acid
Prior art date
Application number
NO20002721A
Other languages
English (en)
Other versions
NO315704B1 (no
NO20002721D0 (no
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20002721D0 publication Critical patent/NO20002721D0/no
Publication of NO20002721L publication Critical patent/NO20002721L/no
Publication of NO315704B1 publication Critical patent/NO315704B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002721A 1997-11-28 2000-05-26 Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse NO315704B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof

Publications (3)

Publication Number Publication Date
NO20002721D0 NO20002721D0 (no) 2000-05-26
NO20002721L true NO20002721L (no) 2000-07-28
NO315704B1 NO315704B1 (no) 2003-10-13

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002721A NO315704B1 (no) 1997-11-28 2000-05-26 Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse

Country Status (32)

Country Link
US (1) US6518270B1 (no)
EP (1) EP1042324B1 (no)
JP (1) JP2001525322A (no)
KR (1) KR20010032559A (no)
CN (1) CN1142933C (no)
AR (1) AR016972A1 (no)
AT (1) ATE233263T1 (no)
AU (1) AU752187C (no)
BR (1) BR9814755A (no)
CA (1) CA2311798A1 (no)
CZ (1) CZ292349B6 (no)
DE (1) DE69811735T2 (no)
DK (1) DK1042324T3 (no)
EE (1) EE04060B1 (no)
ES (1) ES2191356T3 (no)
HU (1) HUP0100601A3 (no)
ID (1) ID24730A (no)
IL (1) IL136145A0 (no)
IS (1) IS5486A (no)
MY (1) MY121032A (no)
NO (1) NO315704B1 (no)
NZ (1) NZ504355A (no)
PL (1) PL340920A1 (no)
PT (1) PT1042324E (no)
RU (1) RU2241000C2 (no)
SE (1) SE9704404D0 (no)
SK (1) SK283904B6 (no)
TR (1) TR200001530T2 (no)
TW (1) TW515798B (no)
UA (1) UA70932C2 (no)
WO (1) WO1999028322A1 (no)
ZA (1) ZA9810468B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0909323T3 (da) 1996-01-04 2007-05-21 Novartis Vaccines & Diagnostic Helicobacter pylori-bakterioferritin
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
ECSP003699A (es) * 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
JP2005530739A (ja) 2002-04-19 2005-10-13 セルラー ジェノミクス，インコーポレーテッド イミダゾ［１，２−ａ］ピラジン−８−イルアミン、生成方法、および使用方法
WO2004022562A1 (en) 2002-09-09 2004-03-18 Cellular Genomics, Inc. 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
US7160885B2 (en) 2003-02-10 2007-01-09 Cgi Pharmaceuticals, Inc. Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
WO2005005429A1 (en) 2003-06-30 2005-01-20 Cellular Genomics, Inc. Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
WO2005019220A2 (en) 2003-08-11 2005-03-03 Cellular Genomics Inc. Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
US8450307B2 (en) 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
KR101913531B1 (ko) * 2004-07-28 2018-10-30 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
WO2006013195A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
WO2006025716A1 (en) 2004-09-03 2006-03-09 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
DE602005020957D1 (de) * 2004-09-03 2010-06-10 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
ES2367312T3 (es) 2004-09-03 2011-11-02 Yuhan Corporation DERIVADOS DE PIRROLO [3,2-c] PIRIDINA Y PROCESOS PARA LA PREPARACIÓN DE LOS MISMOS.
JP4989478B2 (ja) * 2004-09-03 2012-08-01 ユーハン・コーポレイション ピロロ［３，２−ｂ］ピリジン誘導体及びその製造方法
WO2007024294A2 (en) 2005-05-03 2007-03-01 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
MX2008015747A (es) 2006-06-06 2008-12-19 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa.
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2252617A1 (en) 2008-02-13 2010-11-24 CGI Pharmaceuticals, Inc. 6-aryl-imidaz0[l, 2-a]pyrazine derivatives, method of making, and method of use thereof
EA021293B1 (ru) 2008-12-08 2015-05-29 Джилид Коннектикут, Инк. ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
SG171991A1 (en) 2008-12-08 2011-07-28 Gilead Connecticut Inc Imidazopyrazine syk inhibitors
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
PT2545052E (pt) 2010-03-11 2015-02-18 Gilead Connecticut Inc Inibidores da syk à base de imidazopiridinas
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
MD4684B1 (ro) 2013-07-30 2020-03-31 Gilead Connecticut INc. Formulări pe bază de imidazopirazine în calitate de inhibitori SYK
ES2822285T3 (es) 2013-07-30 2021-04-30 Kronos Bio Inc Polimorfo de inhibidores de SYK
EP3076976B1 (en) 2013-12-04 2020-09-02 Gilead Sciences, Inc. Methods for treating cancers
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
AU2015290000B2 (en) 2014-07-14 2018-05-17 Gilead Sciences, Inc. Combinations for treating cancers
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
US11384082B2 (en) 2017-08-25 2022-07-12 Kronos Bio, Inc. Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
US11339168B2 (en) 2019-02-22 2022-05-24 Kronos Bio, Inc. Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス．エー． バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) * 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
PT97467A (pt) * 1990-04-27 1992-01-31 Byk Gulden Lomberg Chem Fab Processo para preparacao de novas piridazinas e de composicoes farmaceuticas que as contem
US5041442A (en) * 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
AU8712191A (en) 1990-10-15 1992-05-20 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazines
WO1993008190A1 (de) * 1991-10-25 1993-04-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
CZ283216B6 (cs) * 1994-01-19 1998-02-18 Sankyo, Company Limited Pyrrolopyridazinové deriváty
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
WO1999028322A1 (en) 1999-06-10
CA2311798A1 (en) 1999-06-10
CN1142933C (zh) 2004-03-24
AR016972A1 (es) 2001-08-01
ZA9810468B (en) 1999-05-21
EP1042324B1 (en) 2003-02-26
NZ504355A (en) 2001-12-21
DE69811735D1 (de) 2003-04-03
US6518270B1 (en) 2003-02-11
MY121032A (en) 2005-12-30
NO315704B1 (no) 2003-10-13
HUP0100601A3 (en) 2002-10-28
ES2191356T3 (es) 2003-09-01
SK6742000A3 (en) 2001-03-12
AU752187B2 (en) 2002-09-12
AU752187C (en) 2003-09-18
BR9814755A (pt) 2000-10-03
IS5486A (is) 2000-05-10
ID24730A (id) 2000-08-03
AU1356599A (en) 1999-06-16
EE200000315A (et) 2001-10-15
NO20002721D0 (no) 2000-05-26
KR20010032559A (ko) 2001-04-25
SK283904B6 (sk) 2004-04-06
TR200001530T2 (tr) 2000-11-21
IL136145A0 (en) 2001-05-20
ATE233263T1 (de) 2003-03-15
HK1030216A1 (en) 2001-04-27
EP1042324A1 (en) 2000-10-11
UA70932C2 (uk) 2004-11-15
EE04060B1 (et) 2003-06-16
HUP0100601A2 (hu) 2001-09-28
DK1042324T3 (da) 2003-05-05
TW515798B (en) 2003-01-01
CZ292349B6 (cs) 2003-09-17
CZ20001947A3 (cs) 2000-11-15
PT1042324E (pt) 2003-06-30
RU2241000C2 (ru) 2004-11-27
SE9704404D0 (sv) 1997-11-28
DE69811735T2 (de) 2003-12-18
CN1284078A (zh) 2001-02-14
JP2001525322A (ja) 2001-12-11
PL340920A1 (en) 2001-03-12

Similar Documents

Publication Publication Date Title
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
NO20013736L (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO985368D0 (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
IS5245A (is) Lyfjablanda úr ómeprasól
DK0927192T3 (da) Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
NO985262L (no) Nye fosfonsyresubstituerte benzazepinon-N-edikksyrederivater, fremgangsmÕte for deres fremstilling, og legemidler inneholdende slike
NO20005430L (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser
DK0502314T3 (da) Benzimidazoler, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
NO934501D0 (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmaat e for deres fremstilling
NO922940D0 (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
DK1117661T3 (da) Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO932636L (no) Benzimidazoler, medikamenter inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
DK0842927T3 (da) 3-Amido-chromanylsulfonyl(thio)urinstoffer, fremgangsmåder til deres fremstilling, deres anvendelse og farmaceutiske præparater med indhold deraf
IS6402A (is) Nýjar greinóttar setnar amínó afleiður af 3-amínó-1-fenýl-1H[1,2,4]tríazóli, aðferðir til framleiðslu á þeim og lyfjasamsetningar sem innihalda þær
NO994209D0 (no) FremgangsmÕte for fremstilling av 2-[[(2-pyridinyl)metyl]sulfinyl]-1H-benzimidazoler og nye forbindelser til anvendelse for dette formÕl
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
NO20013878L (no) (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
DK1165528T3 (da) Hidtil ukendte morpholinoderivater, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse